[Form 4] Savers Value Village, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 filing for Kodiak Sciences Inc. (KOD) discloses that officer John A. Borgeson received a stock-option grant covering 250,000 shares of common stock on 07/04/2025 at an exercise price of $3.95 per share.

The option vests on a standard four-year schedule:

• 1/48th (≈5,208 shares) vests one month after 07/01/2025
• The remaining 47/48th vests in equal monthly installments thereafter, subject to continuous service

No shares were bought or sold outright; this is a new award that increases Borgeson’s potential ownership to 250,000 derivative securities held directly. The grant expires on 07/03/2035.

Investors should note that the award may create modest future dilution if exercised, but it also strengthens long-term alignment between the executive and shareholders.

Insights

Corporate Governance Expert

TL;DR: Routine option grant; aligns incentives, limited immediate impact; modest future dilution possible.

The Form 4 shows a single compensatory grant rather than an open-market transaction. At 250,000 options, the award is meaningful for the individual but immaterial relative to Kodiak’s total shares outstanding. The four-year, monthly vesting schedule is standard and promotes retention. No cash outflow or insider sentiment signal is present because no shares were purchased or sold. Potential dilution equals 250,000 shares, but that is minor unless numerous similar grants accumulate. Overall, governance practices appear conventional and shareholder-friendly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geisser Melinda L.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Services Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/03/2025		M		12,000	A	$1.41	12,000	D
Common Stock	07/03/2025		M		36,000	A	$1.41	48,000	D
Common Stock	07/03/2025		S(1)		48,000	D	$10.7967(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	07/03/2025		M			12,000	(4)	06/12/2029	Common Stock	12,000	$0	596,373(5)	D
Option (Right to Purchase)(3)	$1.41	07/03/2025		M			36,000	(4)	06/12/2029	Common Stock	36,000	$0	560,373(6)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on September 15, 2023.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.49 to $10.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

5. Approximately 36% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting March 28, 2020, and approximately 64% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

6. Approximately 32% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting March 28, 2020, and approximately 68% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

	/s/ Richard Medway, attorney in fact	07/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.